Inflammatory Bowel Disease in Pregnancy

Inflammatory bowel disease (IBD) presents unique clinical considerations related to fertility, medical therapy, and delivery planning. The strongest predictor of adverse pregnancy outcomes is active disease, making maintenance of remission a central management priority. Prepregnancy counseling for patients with IBD should address reproductive goals, nutritional status, and the potential effect of prior pelvic surgery on fertility. Most established IBD therapies, including aminosalicylates, thiopurines, and biologic agents, can be continued to maintain remission, whereas methotrexate is contraindicated, and Janus kinase inhibitors and sphingosine-1-phosphate receptor modulators are generally avoided. Delivery planning should be individualized, with cesarean delivery generally favored for active perianal Crohn disease or rectovaginal fistula and shared decision making emphasized for patients with an ileal pouch-anal anastomosis. Optimal outcomes depend on coordinated multidisciplinary care that prioritizes disease control, treatment continuation, and individualized reproductive and delivery planning.

Authors

Institutions

Publication Details

Journal
Obstetrics and Gynecology
Published
2026-11-17
DOI
https://doi.org/10.1097/aog.0000000000006460
Primary Topic
Pregnancy and Medication Impact
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Inflammatory Bowel Disease in Pregnancy

Sunanda V. Kane, Taylor Boyd
Obstetrics and Gynecology
Pregnancy and Medication Impact
article

Inflammatory Bowel Disease in Pregnancy

Sunanda V. Kane, Taylor Boyd
article en

Abstract

Inflammatory bowel disease (IBD) presents unique clinical considerations related to fertility, medical therapy, and delivery planning. The strongest predictor of adverse pregnancy outcomes is active disease, making maintenance of remission a central management priority. Prepregnancy counseling for patients with IBD should address reproductive goals, nutritional status, and the potential effect of prior pelvic surgery on fertility. Most established IBD therapies, including aminosalicylates, thiopurines, and biologic agents, can be continued to maintain remission, whereas methotrexate is contraindicated, and Janus kinase inhibitors and sphingosine-1-phosphate receptor modulators are generally avoided. Delivery planning should be individualized, with cesarean delivery generally favored for active perianal Crohn disease or rectovaginal fistula and shared decision making emphasized for patients with an ileal pouch-anal anastomosis. Optimal outcomes depend on coordinated multidisciplinary care that prioritizes disease control, treatment continuation, and individualized reproductive and delivery planning.

Obstetrics and Gynecology
Mayo Clinic (US)
Good health and well-being
Pregnancy and Medication Impact
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon